Cite
APA Citation
Martinello, M., Bhagani, S., Gane, E., Orkin, C., Cooke, G., Dore, G. J., Petoumenos, K., Applegate, T. L., Tu, E., Marks, P., Pagani, N., Grebely, J., Nelson, M., & Matthews, G. V. (2018). shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection. Journal of viral hepatitis, 25(10), 1180–1188. http://access.bl.uk/ark:/81055/vdc_100069106605.0x00002e